Pharmaceutical outsourcing partner, the Wasdell Group (Wasdell), has been granted an Investigational Medicinal Product (IMP) license by the Health Products Regulatory Authority (HPRA) at its Dundalk, Ireland facility.    This license enables Wasdell to expand the facility’s services to include clinical importation and distribution. Wasdell’s facilities in Swindon and Newcastle, UK already have an IMP license.    “The licence is particularly important for our EU hub in Dundalk as it allows us to ...